596 related articles for article (PubMed ID: 24607406)
1. CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis.
Todaro M; Gaggianesi M; Catalano V; Benfante A; Iovino F; Biffoni M; Apuzzo T; Sperduti I; Volpe S; Cocorullo G; Gulotta G; Dieli F; De Maria R; Stassi G
Cell Stem Cell; 2014 Mar; 14(3):342-56. PubMed ID: 24607406
[TBL] [Abstract][Full Text] [Related]
2. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
Lim YC; Kang HJ; Moon JH
Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
[TBL] [Abstract][Full Text] [Related]
3. miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.
Yu Y; Nangia-Makker P; Farhana L; G Rajendra S; Levi E; Majumdar AP
Mol Cancer; 2015 May; 14():98. PubMed ID: 25928322
[TBL] [Abstract][Full Text] [Related]
4. KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancer.
Ribeiro KB; da Silva Zanetti J; Ribeiro-Silva A; Rapatoni L; de Oliveira HF; da Cunha Tirapelli DP; Garcia SB; Feres O; da Rocha JJ; Peria FM
Cancer Biomark; 2016 Mar; 16(4):513-21. PubMed ID: 27062566
[TBL] [Abstract][Full Text] [Related]
5. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
Recio JA; Merlino G
Cancer Res; 2003 Apr; 63(7):1576-82. PubMed ID: 12670907
[TBL] [Abstract][Full Text] [Related]
7. Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor/Met and beta-catenin/Wnt pathways.
Previdi S; Maroni P; Matteucci E; Broggini M; Bendinelli P; Desiderio MA
Eur J Cancer; 2010 Jun; 46(9):1679-91. PubMed ID: 20350802
[TBL] [Abstract][Full Text] [Related]
8. CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance.
Ni J; Cozzi PJ; Hao JL; Beretov J; Chang L; Duan W; Shigdar S; Delprado WJ; Graham PH; Bucci J; Kearsley JH; Li Y
Prostate; 2014 May; 74(6):602-17. PubMed ID: 24615685
[TBL] [Abstract][Full Text] [Related]
9. Silibinin, A Natural Blend In Polytherapy Formulation For Targeting Cd44v6 Expressing Colon Cancer Stem Cells.
Patel S; Waghela B; Shah K; Vaidya F; Mirza S; Patel S; Pathak C; Rawal R
Sci Rep; 2018 Nov; 8(1):16985. PubMed ID: 30451890
[TBL] [Abstract][Full Text] [Related]
10. Study of the interaction among Notch pathway receptors, correlation with stemness, as well as their interaction with CD44, dipeptidyl peptidase-IV, hepatocyte growth factor receptor and the SETMAR transferase, in colon cancer stem cells.
Apostolou P; Toloudi M; Ioannou E; Kourtidou E; Chatziioannou M; Kopic A; Komiotis D; Kiritsis C; Manta S; Papasotiriou I
J Recept Signal Transduct Res; 2013 Dec; 33(6):353-8. PubMed ID: 23964856
[TBL] [Abstract][Full Text] [Related]
11. MET signaling in colon cancer stem-like cells blunts the therapeutic response to EGFR inhibitors.
Luraghi P; Reato G; Cipriano E; Sassi F; Orzan F; Bigatto V; De Bacco F; Menietti E; Han M; Rideout WM; Perera T; Bertotti A; Trusolino L; Comoglio PM; Boccaccio C
Cancer Res; 2014 Mar; 74(6):1857-69. PubMed ID: 24448239
[TBL] [Abstract][Full Text] [Related]
12. Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells.
Yang YM; Chang JW
Cancer Invest; 2008 Aug; 26(7):725-33. PubMed ID: 18608209
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cell-associated miRNAs serve as prognostic biomarkers in colorectal cancer.
Toden S; Kunitoshi S; Cardenas J; Gu J; Hutchins E; Van Keuren-Jensen K; Uetake H; Toiyama Y; Goel A
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30895943
[TBL] [Abstract][Full Text] [Related]
14. Cell biological profiling of reprogrammed cancer stem cell-like colon cancer cells maintained in culture.
Hirashima K; Yue F; Kobayashi M; Uchida Y; Nakamura S; Tomotsune D; Matsumoto K; Takizawa-Shirasawa S; Yokoyama T; Kanno H; Sasaki K
Cell Tissue Res; 2019 Mar; 375(3):697-707. PubMed ID: 30284085
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel CD44v6-binding peptides that block CD44v6 and deliver a pro-apoptotic peptide to tumors to inhibit tumor growth and metastasis in mice.
Khan F; Gurung S; Gunassekaran GR; Vadevoo SMP; Chi L; Permpoon U; Haque ME; Lee YK; Lee SW; Kim S; Lee B
Theranostics; 2021; 11(3):1326-1344. PubMed ID: 33391537
[TBL] [Abstract][Full Text] [Related]
16. C-met inhibition blocks bone metastasis development induced by renal cancer stem cells.
D'Amico L; Belisario D; Migliardi G; Grange C; Bussolati B; D'Amelio P; Perera T; Dalmasso E; Dalle Carbonare L; Godio L; Comoglio P; Trusolino L; Ferracini R; Roato I
Oncotarget; 2016 Jul; 7(29):45525-45537. PubMed ID: 27322553
[TBL] [Abstract][Full Text] [Related]
17. Head neck squamous cell carcinoma c-Met⁺ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis.
Sun S; Wang Z
Int J Cancer; 2011 Nov; 129(10):2337-48. PubMed ID: 21225626
[TBL] [Abstract][Full Text] [Related]
18. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer.
Pang R; Law WL; Chu AC; Poon JT; Lam CS; Chow AK; Ng L; Cheung LW; Lan XR; Lan HY; Tan VP; Yau TC; Poon RT; Wong BC
Cell Stem Cell; 2010 Jun; 6(6):603-15. PubMed ID: 20569697
[TBL] [Abstract][Full Text] [Related]
19. Expression of osteopontin, a target gene of de-regulated Wnt signaling, predicts survival in colon cancer.
Rohde F; Rimkus C; Friederichs J; Rosenberg R; Marthen C; Doll D; Holzmann B; Siewert JR; Janssen KP
Int J Cancer; 2007 Oct; 121(8):1717-23. PubMed ID: 17565744
[TBL] [Abstract][Full Text] [Related]
20. Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery.
Di Franco S; Bianca P; Sardina DS; Turdo A; Gaggianesi M; Veschi V; Nicotra A; Mangiapane LR; Lo Iacono M; Pillitteri I; van Hooff S; Martorana F; Motta G; Gulotta E; Lentini VL; Martorana E; Fiori ME; Vieni S; Bongiorno MR; Giannone G; Giuffrida D; Memeo L; Colarossi L; Mare M; Vigneri P; Todaro M; De Maria R; Medema JP; Stassi G
Nat Commun; 2021 Aug; 12(1):5006. PubMed ID: 34408135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]